MPR

FDA Issues Third CRL for Reproxalap in Dry Eye Disease

Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...

FDA rejects Aldeyra's dry eye drug for third time, stock crashes 68%

Aldeyra Therapeutics Inc. ALDX shares are tumbling on Tuesday following the U.S. Food and Drug Administration (FDA) update.
Fierce Biotech

FDA rejects Aldeyra dry eye disease drug for 3rd time, citing inconsistent study findings

After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...
BioSpace

Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting

In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
InvestorsHub on MSN

Aldeyra receives FDA rejection for dry eye treatment reproxalap

Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug Administration rejecting its New Drug Application for reproxalap, a proposed ...
Ophthalmology Times

Aldeyra receives third complete response letter for reproxalap

The US Food and Drug Administration (FDA) has issued a Complete Response Letter to Aldeyra Therapeutics for its New Drug Application of reproxalap for the treatment of dry eye dis ...

Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced ...

Experts warn that popular eyelash extensions can trigger severe eye condition

Health experts have warned that eyelash extensions - a popular beauty treatment used to lengthen and thicken natural lashes - ...
The Manila Times

Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation

Kensington, MD, USA and Munich/Martinsried, Germany, March 12, 2026 (GLOBE NEWSWIRE) -- Galimedix Therapeutics earns milestone payment in ophthalmology partnership ...
Medscape

Light Therapy May Improve Vision in Patients With Dry AMD

Light therapy with multiple wavelengths may safely improve vision, reduce new retinal damage, and improve vision related quality of life in patients with dry age related macular degeneration.
Ophthalmology Times

Mixed signals and mounting frustrations: ophthalmologists on dry eye disease

Fluctuating vision is the most frequently cited complaint, exceeding classic discomfort symptoms, and may divert patients toward refractive explanations before DED is recognized and treated.
The Advocate

The Baton Rouge Clinic elevates local vision treatment with new Eye Care Center

The Baton Rouge Clinic has opened a newly expanded Eye Care Center at 7479 Perkins Road, bringing enhanced access, advanced diagnostic technology and a full-service optical shop to patients across ...